Cargando…
Tenovin-6 inhibits proliferation and survival of diffuse large B-cell lymphoma cells by blocking autophagy
Diffuse large B-cell lymphoma (DLBCL) is one of the most aggressive non-Hodgkin lymphomas. It is curable but one-third of cases are refractory to therapy or relapse after initial response highlighting the urgent need for developing novel therapeutic approaches. Targeting sirtuins, particularly SIRT1...
Autores principales: | Yuan, Hongfeng, He, Meilan, Cheng, Fan, Bai, Rosemary, da Silva, Suzane Ramos, Aguiar, Ricardo C.T., Gao, Shou-Jiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5362454/ https://www.ncbi.nlm.nih.gov/pubmed/28118604 http://dx.doi.org/10.18632/oncotarget.14741 |
Ejemplares similares
-
Tenovin-6 impairs autophagy by inhibiting autophagic flux
por: Yuan, Hongfeng, et al.
Publicado: (2017) -
Correction: Tenovin-6 impairs autophagy by inhibiting autophagic flux
por: Yuan, Hongfeng, et al.
Publicado: (2018) -
Heterogeneous Responses of Gastric Cancer Cell Lines to Tenovin-6 and Synergistic Effect with Chloroquine
por: Ke, Xiangyu, et al.
Publicado: (2020) -
Dysregulation of autophagy in chronic lymphocytic leukemia with the small-molecule Sirtuin inhibitor Tenovin-6
por: MacCallum, Stephanie F., et al.
Publicado: (2013) -
Autophagic flux blockage by accumulation of weakly basic tenovins leads to elimination of B-Raf mutant tumour cells that survive vemurafenib
por: Ladds, Marcus J. G. W., et al.
Publicado: (2018)